Jazz Pharmaceuticals (JAZZ +7.9%) double up on its AH gain yesterday following its upward...

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor

Jazz Pharmaceuticals (JAZZ +7.9%) double up on its AH gain yesterday following its upward revision for 2012 revenue. Adding to the momentum, analysts at Muzho upped their price target on shares to $62 from $52 based on the firm's rosy outlook.